Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism Nav1.6 modulators(Sodium channel protein type VIII alpha subunit modulators) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC44H55N5O8 |
InChIKeyMMSJGCPNUMWOAQ-GTKRZRNESA-N |
CAS Registry2211973-12-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Demyelinating Autoimmune Diseases, CNS | Preclinical | United States | 01 Feb 2019 | |
Nervous System Paraneoplastic Syndromes | Preclinical | United States | 01 Feb 2019 |